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ABSTRACT OF THESIS:  
To demonstrate an analysis for isoniazid from aqueous mixtures and solid tablets, utilizing 
isocratic conditions, with high performance liquid chromatography (HPLC) and UV detection. 
Isoniazid in solid and liquid samples is assayed utilizing HPLC. Isoniazid is a tuberculostat, that 
is assayed by high performance liquid chromatography that utilizes a reversed-phase C-18 column. 
The eluent solvent is 5.3% ethanol, 93.7% water, and 1% acetic acid. Aqueous samples are 
prepared in distilled water as the solvent. The ultraviolet-visible detection of isoniazid is 
accomplished at 265 nm, which is the wavelength having the highest sensitivity for isoniazid.  
Having a column pump pressure at 2100 psig, rise time 0.1, and with flow rate 1.0 mL/minute, the 
elution of isoniazid occurred at 2.2 minutes. The standard curve that was applied ranged from zero 
to 0.001460 molar in concentration (y = 50,237,766.7435 x). The model described by the standard 
curve had a coefficient of determination of R2 = 0.9921, and a very strong positive correlation 
coefficient (r= 0.9960). Percent recovery of drug ranged from 97.3% to 105%. Utilizing reversed 
phase column with isocratic solvent conditions is shown here to be an effective methodology for 
determination of isoniazid. 
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INTRODUCTION 
 
Tuberculosis, (TB, Mycobacterium tuberculosis) is a deadly infectious disease caused by 
various strains of mycobacteria, particularly the Mycobacterium tuberculosis in humans. 
Tuberculosis most often attacks the lungs; however, it can also infect other parts of the body as 
extra-pulmonary tuberculosis. The bacteria spreads through the air when people carrying the 
disease cough, sneeze, or spit. Often times in humans, the result is an asymptomatic, latent 
infection [1]. However, about ten percent of latent infections eventually progresses to active 
disease, which can kill more than 50% of its victims if not treated [1]. 
Tuberculosis meningitis is caused by the bacterium that is the causative agent of pulmonary 
tuberculosis, Mycobacterium tuberculosis, and is an infection of the meninges (the dura mater, 
arachnoid, and pia mater that line the skull and vertebral canal which enclose the brain and spinal 
cord) [1]. Various risk factors that increase the possibility of central nervous system (CNS) 
infection include pulmonary tuberculosis and various other disorders that compromise the immune 
system [1]. Mycobacterium tuberculosis can infect the CNS from an origin located from elsewhere 
in the body [1].  The types of TB infections that involve the central nervous system can be placed 
into three clinical categories [2]: 1) Meningitis, 2) Intracranial tuberculoma, and 3) Spinal 
tuberculous arachnoiditis.  
Clinical treatment of tuberculosis meningitis requires several tuberculostatic drugs that are 
administered simultaneously, with treatment lasting up to 12 months in duration [3].  The clinical 
treatment and control of tuberculosis disease is substantially impaired with the appearance of 
multi-drug resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-
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TB) [3]. The appropriate use of second-line drugs is required to treat cases of MDR-TB, and to 
inhibit the proliferation of XDRTB [1, 2, 3]. 
Tuberculosis is a serious health threat and is thought to cause up to 1.5 million deaths 
annually [4]. With the appearance of drug-resistant strains of tuberculosis and with HIV (human 
immunodeficiency virus) coinfection, the incidence of this disease has increased [4].  Almost one-
third of the world’s population is infected with Mycobacterium tuberculosis [5].  Annually, up to 
8.8 million patients are newly diagnosed with an active infection of tuberculosis [5, 6]. The current 
first-line drugs for treatment (isoniazid, rifampin, pyrazinamide, ethambutol) must be taken for up 
to 6 months to achieve high level of cure rates (>95%) [5, 6].  
 
The molecular structure of isoniazid having the hydrazide group (-C(=O)NHNH2). The 
IUPAC name is pyridine-4-carbohydrazide. This drug has a molecular formula C6H7N3O and 
formula weight 137.14 grams/mole.  The SMILES (simplified molecular-input line-entry system) 
notation is O=C(NN)c1ccncc1. 
Isoniazid is a first-line tuberculostatic agent that is part of the core of TB treatment 
regimens. It has been approved as prophylactic therapy for both latent and active tuberculosis 
infections. It is activated in the body by a bacterial catalase-peroxidase enzyme in Mycobacterium 
tuberculosis called KatG. This prodrug inhibits the synthesis of mycolic acids, which are essential 
Nguyen 7 
 
for the mycobacterial cell wall [7]. It interferes with the metabolism of vitamin B-6 in some 
patients [8]. For active tuberculosis infections, isoniazid is often used in combination with other 
tuberculosis medications, in order to prevent the development of drug resistance. Isoniazid was 
selected for analysis because it is first-line tuberculostatic drug that is a small molecule with 
properties suitable for penetration into the central nervous system and appropriate for treatment of 
tuberculosis infection in the central nervous system. 
 
 
METHODOLOGY 
 
 
Reagents and Instrumentation 
              All solvents are analytical grade and obtained from Sigma-Aldrich (St. Louis MO 63178 
USA). The isoniazid (isonicotinic acid hydrazide) for use as standards and preparation of samples 
is from Sigma (PO Box 2060, Milwaukee Wi 53201). For the high-performance liquid 
chromatography analysis, an Alltech 426 HPLC Pump and Linear UVS 200 detector with 
reversed-phase isocratic conditions was utilized (Deerfield, Illinois 60015-1899). The HPLC 
Alltech instrumentation is controlled by computer interface. 
Instrument Settings, Preparation of Standards and Test Sample 
For analysis by HPLC, a reversed-phase C-18 octadecylsilyl (C18H37) bonded phase 
column packing was utilized. The isoniazid analyte elutes at 2.28 minutes. Detection by ultraviolet 
detector set to 265 nm, rise time 0.1, range AUFS set to 1.0. The HPLC pump was set to 1135 psig 
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and one milliliter per minute flow rate. Actual volume injected into the column is about 20 
microliters. The dead time of eluting non-retained species is 1.5 minutes and calculated based on 
relationship, dead time= to = volume/flow rate = 1.5 mL/1.0 mL/min = 1.5 minutes.  
Sample Types and Samples 
Column solvent utilized throughout the project was made for a total volume of 1000 mL, 
by adding 52.6 mL of 95% ethanol, 937.4 ml of distilled water, and 10 mL of glacial acetic acid 
(stock at 17.4 molar). Therefore, the working concentrations: 5% ethanol, 0.174 molar acetic acid, 
and 93.7% water (v/v). Sample solvent used for solubilizing isoniazid in various test samples: 
distilled water.  Stock standard of isoniazid was prepared by dissolving 1.509 grams of isoniazid 
into 250 mL volumetric flask of distilled water, making a mixture of 6.000 x 10-2 molar.                
If any sample required clarification prior to HPLC analysis, then where necessary, this is 
accomplished by Whatman 6900-2502 GD/X 25 Sterile Syringe Filter, 25 mm, 0.2 Micron, PVDF 
Filtration Medium, with a suitable plastic syringe.  Samples for HPLC analysis were in distilled 
water as solvent, which works exceptionally well for the very water-soluble isoniazid.  Ampoule-
type samples, used in clinical application, were isoniazid drugs prepared in dilute HCl aqueous 
solvent with HCl concentration at 1.00 x 10-6 molar.  Tablet/solid samples consisted of the drug 
isoniazid prepared in various known percentage of combinations of excipients lactose, cellulose, 
starch, and/or dextrin.  After thorough mixing of isoniazid with excipient(s), the tablets were 
prepared utilizing a standard Parr Pellet Press (Parr Instrument Company, 211 Fifty Third Street, 
Moline Illinois 612265 USA).  The pressed tablets were then carefully weighed by digital balance, 
the isoniazid determined by mass percentage present, then followed by solubilizing in distilled 
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water utilizing 100 mL volumetric flasks.  Clarification of solution can be accomplished by syringe 
filter. Samples were then analyzed after 48 hours of mixing/settling and harvesting of supernatant. 
Statistical Analysis and Properties Determination 
 Wherever indicated, the numerical analysis such as correlation of sets of data was 
performed by PAST version 2.06. Summary statistical analysis was accomplished by Microsoft 
Excel, and PAST v. 2.06. To test for outliers, the Grubb’s test was performed by GraphPad InStat, 
version 3.00 for Windows 95. Determination of 95% confidence intervals was accomplished by 
Method Validator version 1.1, and linear regression done by Excel and Method Validator version 
1.1.  Passing-Bablok regression analysis was accomplished by ACOMED statistic (www.acomed-
statistik.de, copyright: Dr. Thomas Keller) and Method Validator version 1.1.     
 
PROJECT DATA AND INTERPRETATION 
 
 
Isoniazid is an important first-line synthetic tuberculostatic drug, having bactericidal 
activity to rapidly dividing mycobacteria and bacteriostatic activity if the mycobacteria are slow-
growing. It easily dissolved in the test samples of distilled water solvents for standards, as well as 
aqueous samples for tablet/ solid preparations. The HPLC analysis was accomplished operating 
under isocratic conditions. During the study, the mobile phase composition remained constant. The 
biggest advantages of these isocratic conditions includes a column being equilibrated at all times 
and a system that does not suffer from fast chemical changes [9].  
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The mobile phase in reversed phase HPLC consists of water as the aqueous solution and 
an organic modifier. Therefore, for the case of reverse phase HPLC, water is the “weakest” solvent. 
Because of the polarity of water, it more readily repels hydrophobic analytes into the stationary 
phase, more so than any other solvent. An organic modifier is added so that a hydrophobic  analyte 
is no longer as so strongly repelled into the stationary phase. The analyte will then elute earlier, 
making the modifier “chromatographically strong” since it is the cause of the elution speed 
increase. The organic modifier utilized in this study is the alcohol ethanol, but other common 
organic modifiers include other alcohols.  
 To signal the elution of isoniazid from the HPLC instrument, it is essential to determine 
the wavelength setting for the UV-Vis detector. The wavelength of detection is set to a wavelength 
where the analyte maximum absorbance occurs in the solvent mixture. To determine isoniazid’s 
maximum wavelength for HPLC detection, mixtures having identical molar concentrations in 
distilled water were injected using constant column and instrument settings. With only the 
wavelength of detection being varied, the wavelength of maximum absorbance was identified, 
which that wavelength selected for this analysis. The wavelengths examined were: 250 nm, 260 
nm, 265 nm, 270 nm, 280 nm, and 290 nm. The maximum absorbance for isoniazid occurred at 
265 nm.  
 Initially, it is necessary to show the wavelength in which the maximum absorbance for 
isoniazid occurs for accurate assay by HPLC. This result is presented in Table 1, with the data  
plotted in Figure 1. The maximum absorbance is at 265 nm, having a peak area determined to be 
34,608.0 uV.Min  . This wavelength is the setting for the UV/Vis detector in determining isoniazid. 
At 290 nm, the wavelength had a peak of 9,618.6 uV.Min. At 280 nm, the peak was 19,805.5; 
double what it was at the first concentration sample. At 270 nm, it almost doubles again, with a 
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peak area of 32,719.4 uV.Min. Post approaching the maximum, the wavelength begins to dip back 
down with 260 nm wavelength having a 31,880.4 uV.Min peak area. The last sample tested gave 
at 250 nm wavelength with a 21,873.6 uV.Min peak area.  The assay of isoniazid will therefore be 
conducted at 265 nm, the the absorbance maxima for isoniazid under these conditions of the HPLC 
instrumentation and drug solubilization. 
TABLE 1 
Wavelength   Peak Area 
  (nm)    (uV. Min) 
  290        9,618.6 
280    19,805.5 
270    32,719.4 
265    34,608.0 
260    31,880.4 
250    21,873.6 
 
 
 
Figure 1. Comparison of peak area to wavelength in nanometers for six sample injections. The 
wavelengths on x-axis and their corresponding peak areas on y-axis are plotted. The highest 
peak area shown is at 265 nm, with a value of 34,608.0 uV. Min. The curve projects roughly a 
bell shaped structure. Concentration of all samples are at 6.000 x 10-4 molar and volume of 
injections at 20 microliters. 
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 Example chromatograms of isoniazid elution are presented in Figures 2a-d below. The peak 
in each of the chromatograms is very well defined and sharp. This was a consistent attribute for 
the isoniazid analysis performed during the study. Elution time of the isoniazid was consistent.  
These sharply defined peaks were utilized for obtaining values for the peak areas and 
concentrations. These peaks appearing in the chromatograms provided quick and trouble-free 
selection by the instrumental software.  The sensitive ultraviolet light detector would have revealed 
any contamination or degradation of the analyte isoniazid, if it had occurred during analysis. No 
evidence of contamination or degradation of analyte was observed during the course of the study. 
 
 
 
Figure 2a. Chromatogram of isoniazid elution from HPLC.  Isoniazid concentration is at 
8.312 x 10-3 molar. Elution of isoniazid peak occurring with a peak area of 42,036.6 uV.Min.  
 
Nguyen 13 
 
 
Figure 2b. Chromatogram of isoniazid elution from HPLC. Isoniazid concentration is at 7.278 x 
10-4 molar with a peak area of 36,803.7 uV.Min. 
 
 
Figure 2c. Chromatogram of isoniazid elution from HPLC. Isoniazid concentration is at 6.150 x 
10-4 molar. Peak showing isoniazid eluting with a calculated peak area of 30,871.8 uV. Min.  
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Figure 2d. Chromatogram of isoniazid elution by HPLC. Isoniazid concentration is at amount 
5.126 x 10-4 molar. Peak showing isoniazid eluting with a calculated peak area of 25,925.0 uV. 
Min. 
 
A standard curve was elucidated for the determination of isoniazid concentration through 
the HPLC assay of aqueous samples, ampoule type samples, and solid tablet based samples that 
are utilized for oral administration.  Prepared standard solutions that were injected and assayed 
produced values that are shown in Table 2.  These values being the basis for determination of 
concentration of isoniazid in the various mixtures analyzed in terms of molarity. The values show 
consistent increase as the concentration of isoniazid is increasing.  The two dimensional plot of 
molarity (x-axis) with respective areas (uV.Min) from generated chromatograms (y-axis), is 
presented in Figure 3.  The result came out to be highly linear, with a coefficient of determination 
of R2 = 0.9921, and a Pearson correlation coefficient of 0.9960.  The Pearson r correlation 
indicating an extremely high positive inter-relationship of concentration to area of peak.  The range 
of detection ranges from 0.000 molar to 1.460 x 10-3 molar. The equation of the line was y = 
50,237,766.7435x. The coefficient of determination becomes R2 = 0.9921, indicating that 99.21% 
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the proportion of the variance in the dependent variable that is predictable from the independent 
variables [10]. 
                                                        TABLE 2 
Molarity Area 
0 0 
0 0 
.000015 2008.5 
.000030 3258.2 
.000150 8182.7 
.000300 16315.1 
.000530 31070.1 
.000600 31779.3 
.000900 45757.8 
.001069 51534.0 
.001146 60419.8 
.001460 69703.1 
 
Formation of Standard Curve for Determination of Sample Concentrations 
 
Figure 3. The standard curve for determination of concentration of drug in mixtures analyzed in 
terms of molar amount. The equation line is y = 50,237,766.7435x with a coefficient of 
determination of R2 = 0.9921 (99.21% is variance in the model). The Pearson r correlation 
coefficient for these concentrations is r = 0.9960 (very strong positive correlation).  
y = 50,237,766.7435x
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0
10000
20000
30000
40000
50000
60000
70000
80000
90000
100000
0 0.0002 0.0004 0.0006 0.0008 0.001 0.0012 0.0014 0.0016
Ar
ea
 
 
 
u
V.
M
in
Concentration (molar) 
Molarity vs Area
Nguyen 16 
 
            For comparing the instrumental parameters utilized in this study for the assay of isoniazid,  
two other medicinal compounds, quinine sulfate and inositol were also injected.  The elution  
observed are seen in the following chromatograms  (see Figures 4 and 5.  Therefore, the instrument  
parameters utilized for isoniazid determination may be appropriate and efficient for other drugs.  
Chromatograms of Selected Agents under Conditions Specified 
 
Figure 4. Chromatogram of quinine sulfate at 4.342 x 10-4 molar (molar mass = 782.96 
grams/mole). HPLC conditions include detection at 265 nm, flow rate 1.00 mL/minute, rise 
time 0.1, and range AUFS 1.0. Solvent is 94% water, 5 % ethanol, and 1% acetic acid. 
 
Figure 5. Chromatogram of inositol at 1.998 x 10-3 molar (molar mass = 180.16 grams/mole). 
HPLC conditions include detection at 265 nm, flow rate 1.00 mL/minute, rise time 0.1, and 
range AUFS 1.0. Solvent is 94 % water, 5 % ethanol, and 1 % acetic acid.  
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Analyte recovery was consistent and precise in this study. The recovery rate for isoniazid 
utilizing HPLC is presented in Table 3. The calculated molar values are determined from the 
molarity of the stock solution dissolved in aqueous solution from the HPLC standard curve 
analysis. The six samples all had a recovery percentage range of 97.3-105%. The Grubb’s test 
indicated no outliers were present.   Percent recovery of drug samples, comparing calculated 
molarity concentration to values from HPLC standard curve analysis resulted in average percent 
recovery at 100.2%. The standard deviation s = 3.43, with a variance of s2 = 11.756.    The 
calculated molar values in comparison to HPLC measured molar values shows an excellent 
relationship by Passing-Bablok regression (slope = 0.9725, y-axis intercept = 0.000). The 
calculated 95% confidence interval for the y-axis intercept includes the value of zero (0.00 to 
0.00) and the 95% confidence interval for the slope does include 1 (0.9488to 1.000). Therefore, 
there are no constant differences between the calculated values of concentration and the HPLC 
measured values, so these values can be used interchangeably. Therefore, the calculated molar 
values are representative of the HPLC measured molar values.  Passing – Bablok regression 
analysis allows comparison of two measurement methods for method comparison studies [11].  
                                                                TABLE 3 
DISSOLVED SAMPLE OF ISONIAZID, PERCENT RECOVERY  
Sample Concentration by 
Calculated Value 
 
Concentration by 
HPLC Standard 
Curve Analysis 
Percent 
Recovery 
1 8.583x10-4 8.348x10-4 97.3 
2 1.108x10-3 1.101x10-3 99.4 
3 9.515x10-4 9.993x10-4 105 
4 1.101x10-3 1.080x10-3 98.1 
5 1.133x10-3 1.178x10-3 104 
6 1.062x10-3 1.034x10-3 97.4 
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        The percent recovery of isoniazid from ampoule type storage of this drug that is intended  
for clinical usage was also measured, with the outcome presented in Table 4.   Average percent  
recovery is 100.67% with Standard deviation s = 0.577, in addition, having a variance of s2 =  
0.333.   Analysis of Table 4 calculated molar values, when in comparison to HPLC measured  
molar values does show an excellent relationship by Passing-Bablok  regression (slope = 0.9725,  
y-axis intercept = 0.000). With the 95% confidence interval for the y-axis intercept including  
zero (0.00 to 0.00) and the 95% confidence interval for the slope including 1 (0.9488to 1.000).  
Therefore, again, there are no constant differences between the calculated and HPLC measured  
values, and these values can be used interchangeably. Therefore, the calculated molar values are  
representative of the HPLC measured molar values [11]. 
 
TABLE 4 
AMPOULE SAMPLE OF ISONIAZID, PERCENT RECOVERY 
Sample Concentration by 
Calculated Value 
 
Concentration by 
HPLC Standard 
Curve Analysis 
Percent 
Recovery 
1 6.450 x 10-4 6.536 x 10-4 101 
2 7.800 x 10-4 7.835 x 10-4 100 
3 8.850 x 10-4 8.926 x 10-4 101 
 
       Clearly, isoniazid is a very important antibacterial agent for the treatment of pulmonary  
tuberculosis and extra-pulmonary tuberculosis.  Methods to assay isoniazid will be highly useful  
for patient compliance verification, quality control in industrial production, and clinical  
verification of pharmaceutical content.  The methodology that is demonstrated in this study is  
sensitive, efficient, consistent, and accurate. The use of HPLC for assay of drugs is a powerful  
and versatile approach to achieve high levels of sensitivity and precision.  HPLC is effective for  
isoniazid determination. 
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CONCLUSION 
 
 
This study demonstrates the efficacy of isocratic determination of isoniazid – an important 
drug for the treatment of tuberculosis.  The study shows that isoniazid can be assayed from aqueous 
mixtures as well as from solid origins.  Detection is consistent, accurate, and over a broad range 
of concentrations.  The standard curve detected amounts from 0 molar to 0.001460 molar. The 
coefficient of determination obtained as R2 = 0.9921 explanations for 99.21% of the variance in 
the dependent variable. Percent recovery of analyte is very high.  The standard curve is linear and 
has an extremely high positive correlation with peak areas derived from HPLC analysis.  
The instrumental analysis of pharmaceutical products meant for human consumption is a 
vital function of analytical chemistry. The methodologies have become tools for identifying 
substitutes in products by manufacturers and contaminants. The types of instruments allow 
investigators a broad range of choices, giving the analysis of products by HPLC to continue to be 
a successful area of application, due to its high sensitivity of detection. This methodology will be 
useful for clinical monitoring and industrial manufacturing of this important drug, allowing 
confidence in the quality of available pharmaceutical products in medical facilities.  
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